Active sensitization to budesonide and para-phenylenediamine from patch testing.
Le Coz
C J
CJ
Consultation de Dermato-Allergie, Clinique Dermatologique des Hôpitaux Universitaires de Strasbourg, France.
El Bakali
A
A
Untereiner
F
F
Grosshans
E
E
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D019819:Budesonide / Q000009:adverse effects*; D004396:Coloring Agents / Q000009:adverse effects*; D009783:Dermatitis, Occupational / Q000175:diagnosis / Q000209:etiology*; D003937:Diagnosis, Differential; D005533:Foot Dermatoses / Q000175:diagnosis / Q000209:etiology*; D005938:Glucocorticoids; D006229:Hand Dermatoses / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D008297:Male; D016273:Occupational Exposure / Q000009:adverse effects*; D010328:Patch Tests; D010655:Phenylenediamines / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D004396:Coloring Agents; D005938:Glucocorticoids; D010655:Phenylenediamines; D019819:Budesonide; C029728:4-phenylenediamine